IL6 and relapsing-remitting multiple sclerosis: The findings from this pilot study, therefore, do not seem to support our hypothesis that cetirizine, via its multiple modulatory effects on allergic and inflammatory responses that include the down-regulation of IL-6, might alleviate IFNβ-induced FLS in RRMS patients not adequately controlled by paracetamol or NSAIDs.